$ONCT Oncternal Therapeutics, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Oncternal Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Oncternal Therapeutics, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Oncternal Therapeutics, Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| AKER HAZEL M | Legal Counsel | 46,987 | 262,187 | shares bought: 51,271 / shares sold: 0 | STRONG BUY | Jul 23 2020 | 24 months ago |
| Barnette K Gary | Vice President | 0 | 0 | Jan 02 2008 | |||
| BILINSKY IGOR | Chief Business Officer | 0 | 0 | Mar 18 2020 | |||
| BREITMEYER JAMES B | Chief Executive Officer | 255,591 | 1,426,198 | shares bought: 277,868 / shares sold: 0 | STRONG BUY | Mar 22 2021 | 15 months ago |
| Brown Michael Denny | Vice President | 0 | 0 | May 01 2008 | |||
| CARTER MICHAEL G | Director | 71,947 | 401,464 | shares bought: 142,858 / shares sold: 0 | STRONG BUY | Sep 02 2020 | 22 months ago |
| CARTER MICHAEL G | Director | 371 | 2,070 | Jan 05 2009 | |||
| CARTER MICHAEL G | Director | 36,320 | 202,666 | May 08 2014 | |||
| Cho Man | Director | 0 | 0 | Jun 12 2020 | 25 months ago | ||
| CLARKSON ANDREW M | Director | 160,025 | 892,940 | Jul 02 2008 | |||
| Dalton James T | Vice President | 0 | 0 | Jan 05 2009 | |||
| DALTON JAMES T | VP, Chief Scientific Officer | 72,883 | 406,687 | Jul 03 2014 | |||
| Deener Gregory A | Vice President | 825 | 4,604 | Jan 28 2009 | |||
| DEENER GREGORY A | Vice President | 27,500 | 153,450 | Jan 04 2011 | |||
| Dodson Shontelle | Vice President | 0 | 0 | May 05 2008 | |||
| DOGGRELL HENRY PATTON | VP, Chief Legal Officer | 43,630 | 243,455 | shares bought: 0 / shares sold: -12,316 | STRONG SELL | Jun 22 2018 | |
| DOGGRELL HENRY PATTON | VP, Chief Legal Officer | 602,913 | 3,364,255 | Feb 20 2015 | |||
| FEINBERG LARRY N | 10% Owner | 2,292,360 | 12,791,369 | Aug 18 2004 | |||
| Furr Barry J. A. | Director | 48,469 | 270,457 | Jan 06 2015 | |||
| GLASS J KENNETH | Director | 183,768 | 1,025,425 | May 06 2016 | |||
| GLASS J KENNETH | Director | 48,553 | 270,926 | Feb 17 2009 | |||
| GLASS J KENNETH | Director | 40,550 | 226,269 | May 08 2014 | |||
| HALE DAVID F | Director | 699,406 | 3,902,685 | shares bought: 717,752 / shares sold: 0 | STRONG BUY | Jun 12 2020 | 25 months ago |
| HANOVER MARC STEVEN | Chief Executive Officer | 129,990 | 725,344 | shares bought: 123,456 / shares sold: -7,309 | BUY | Jan 09 2018 | |
| HANOVER MARC STEVEN | Chief Executive Officer | 1,190,411 | 6,642,493 | Feb 20 2015 | |||
| HESSELBERG JEFFREY G | Vice President, Regulatory | 0 | 0 | May 16 2007 | |||
| HESSELBERG JEFFREY G | Vice President, Regulatory | 0 | 0 | Jan 02 2008 | |||
| Hsu Frank J. | Chief Medical Officer | 0 | 0 | Mar 18 2020 | |||
| HYDE JOSEPH R III | Director | 1,939,199 | 10,820,730 | shares bought: 8,943,084 / shares sold: 0 | STRONG BUY | Oct 02 2018 | |
| HYDE JOSEPH R III | Director | 7,630,127 | 42,576,109 | Feb 02 2009 | |||
| HYDE JOSEPH R III | Director | 39,552,567 | 220,703,324 | Jan 06 2015 | |||
| Karr Robert W | Director | 5,224 | 29,150 | Jan 05 2009 | |||
| KARR ROBERT W | Director | 0 | 0 | May 04 2010 | |||
| Kaufmann Gunnar F. | Chief Scientific Officer | 0 | 0 | Mar 18 2020 | |||
| KISNER DANIEL L | Director | 10,000 | 55,800 | shares bought: 10,000 / shares sold: 0 | BUY | Jul 23 2020 | 24 months ago |
| LARUE WILLIAM R | Director | 16,144 | 90,084 | shares bought: 26,174 / shares sold: 0 | STRONG BUY | Jun 12 2020 | 25 months ago |
| Liu Yanjun | Director | 0 | 0 | Sep 16 2019 | |||
| MAZANET ROSEMARY | Director | 22,782 | 127,124 | May 27 2021 | 13 months ago | ||
| MAZANET ROSEMARY | Director | 0 | 0 | May 11 2009 | |||
| MORTON RONALD A JR | VP, Chief Medical Officer | 0 | 0 | Jan 05 2009 | |||
| MORTON RONALD A JR | VP, Chief Medical Officer | 0 | 0 | Jan 04 2012 | |||
| MOSTELLER MARK EDWARD | Vice President and CFO | 0 | 0 | Jan 05 2009 | |||
| MOSTELLER MARK EDWARD | Vice President, CFO | 0 | 0 | Jul 10 2013 | |||
| Nakanishi Xin | Director | 0 | 0 | Jun 12 2020 | 25 months ago | ||
| NEIL GARRY ARTHUR | Director | 36,759 | 205,115 | shares bought: 40,854 / shares sold: 0 | STRONG BUY | Jan 03 2019 | |
| PONTIUS JOHN HOFMANN | Director | 64,914 | 362,220 | Jan 05 2009 | |||
| PONTIUS JOHN HOFMANN | Director | 86,558 | 482,994 | Jul 05 2011 | |||
| Pyramid Peak Foundation | 10% Owner | 4,390,243 | 24,497,556 | shares bought: 8,281,340 / shares sold: 0 | STRONG BUY | Oct 02 2017 | |
| Robinson Kenneth S | Director | 44,105 | 246,106 | shares bought: 84,097 / shares sold: 0 | STRONG BUY | Oct 02 2018 | |
| ROBINSON KENNETH S | Director | 100,588 | 561,281 | Jan 06 2015 | |||
| Rodriguez Domingo | Vice President | 0 | 0 | May 05 2008 | |||
| SCHULER JACK W | 10% Owner | 6,954,144 | 38,804,124 | Mar 05 2012 | |||
| SCHULER JACK W | 10% Owner | 6,165,261 | 34,402,156 | Mar 21 2014 | |||
| Sear Timothy R G | Director | 183,640 | 1,024,711 | Jan 27 2009 | |||
| SEAR TIMOTHY R G | Director | 45,668 | 254,827 | Jan 03 2013 | |||
| Shackelford Jason T | Prin Fin. & Acct. Officer | 19,453 | 108,548 | shares bought: 0 / shares sold: -12,369 | STRONG SELL | Jun 22 2018 | |
| Shanghai Pharmaceutical (USA) Inc. | 10% Owner | 3,544,431 | 19,777,925 | shares bought: 3,544,431 / shares sold: 0 | STRONG BUY | Jul 23 2020 | 24 months ago |
| STEINER MITCHELL SHUSTER | Chief Executive Officer | 5,100 | 28,458 | Feb 02 2009 | |||
| STEINER MITCHELL SHUSTER | Chief Executive Officer | 1,867,951 | 10,423,167 | Jan 03 2013 | |||
| THEUER CHARLES | Director | 14,677 | 81,898 | shares bought: 14,677 / shares sold: 0 | BUY | Jun 12 2020 | 25 months ago |
| VINCENT RICHARD G | Chief Financial Officer | 40,794 | 227,631 | shares bought: 48,988 / shares sold: 0 | STRONG BUY | Mar 18 2020 | |
| West Christopher K | Vice President - Sales | 0 | 0 | Jan 08 2008 | |||
| Wills Robert James | Director | 137,344 | 766,380 | shares bought: 128,456 / shares sold: 0 | STRONG BUY | May 27 2021 | 13 months ago |
| Young Diane C. | VP, Chief Medical Officer | 47,985 | 267,756 | shares bought: 2,049 / shares sold: -2,014 | BUY | Jul 17 2018 |